Medicines Australia welcomes Government commitment to pharmaceuticals industry

Medicines Australia chief executive Ian Chalmers has congratulated the Government on its establishment of a Pharmaceuticals Industry Strategy Group (PISG).

The initiative was announced by Senator Kim Carr, the Minister for Innovation, Industry, Science and Research. The Group will develop a strategic plan to increase investment in pharmaceuticals R&D, clinical trials and manufacturing in Australia. It will be cochaired by CSL chief executive Dr Brian McNamee.

Mr Chalmers said he was greatly encouraged by Senator Carr’s commitment to a sustainable future for the pharmaceuticals industry.

The Pharmaceuticals Industry Strategy Group will provide an opportunity to address the industry’s most urgent priorities and recommend an effective course of action for Government to consider, Mr Chalmers said.

“This is an opportunity for the pharmaceuticals industry and the Government to put together a strategic plan for the development of the industry in Australia.

“We need to make Australia a globally competitive destination for future investment in R&D, clinical trials and manufacturing of innovate products.”

Senator Carr announced that membership of the Group would include Mr Chalmers, AusBiotech chief executive Dr Anna Lavelle, and Generic Medicines Industry Association chief executive Ms Di Ford. The remaining membership will be finalised shortly.

The Pharmaceuticals Industry Strategy Group will report to the Government by the end of the year.

–ENDS–

Contact Person:

Jamie Nicholson
Media Communications Manager
Phone: 0419 220 293
Email: Jamie.Nicholson@medicinesaustralia.com.au